ijms-logo

Journal Browser

Journal Browser

A New Paradigm for Chaperone Proteins in Health and Disease

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Biology".

Deadline for manuscript submissions: closed (15 November 2022) | Viewed by 6521

Special Issue Editor


E-Mail Website
Guest Editor
National Health Research Institutes, Zhunan, Taiwan
Interests: Hsp60; Hsp10; mitochondrial chaperonins; mitochondrial matrix; immune-regulatory; aging; regeneration; mitochondrial unfold protein response; chaperonopathy; chaperonotherapy; protein folding and transport; heart failure; atherosclerosis; autoimmunity; neural degeneration; free radicals; autophagy; muscular degeneration and regeneration; apoptosis; atrophy and dystrophy; heat shock proteins; stress response; cancers; diabetes; chronic inflammation; fibrosis

Special Issue Information

Dear Colleagues,

Mammalian chaperones, including the families of heat shock proteins, are intriguing in their significance as “old molecules” made up of evolutionarily conserved sequences relating to bacterium, and yet the functions and signaling pathways leading to their activation as well as the consequences of induction in mammalian cells are not completely understood. By taking the mitochondrial chaperones as an example, mitochondrial chaperones, including mtHsp70, Hsp60, and Hsp10, and other assisting members are responsible for the folding of peptides imported into the mitochondrial matrix in addition to the refolding, degrading, and recycling of denatured proteins, thus protecting cells against noxious stress by maintaining mitochondrial homeostasis. The induction of chaperones, including mtHsp70 and Hsp60/10, has been found to be one of the beacons of the unfolded protein response in mitochondria. The association of changes in the expression of mitochondrial chaperones with human disease has been well-documented based on clinical samples from patients with cancer and associations with cancer prognoses, as well as those with cardiovascular and immune diseases; there are also data from animal models of neuronal, muscular, and inflammatory disorders showing the association of the expression of these chaperonins with disease. So far, the findings are far from conclusive. For example, while Hsp60 is elevated under many inflammatory states in various diseases, infringingly, it has long been known that Hsp60 expression in muscular tissues declines with ageing and in patients with metabolic disease, including obesity and diabetes featuring chronic inflammation. 

The roles of mitochondrial chaperones are not limited to mitochondria. For example, inside the cell, Hsp60 and Hsp10 have been localized to the mitochondrial matrix, the cytosol, and the nucleus, and have also been found extracellularly, including inside exosomes. In different locations, Hsp60 binds to and modulates the trafficking and activities of important molecular clients, e.g., p53 and caspase 3, leading to its versatile roles in the cell cycle, apoptosis, senescence, and autophagy via those clients. New mechanisms of regulating the functions of clients by chaperones are continuing to be identified, e.g., the post-translational modification of Hsp60 and the subsequent effects on interactions with its molecular clients present many possibilities for the regulation of important cellular events.

For our Special Issue, entitled “A New Paradigm for Chaperone Proteins in Health and Disease”, we invite original research and review articles on topics related to new findings regarding the roles of chaperone proteins in all areas of biomedicine. We especially encourage the submission of reports on new cellular or animal models, as well as studies demonstrating the therapeutic potential of chaperones as molecular targets in the treatment of human diseases.

Dr. Kurt Ming-Chao Lin
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Hsp60
  • Hsp10
  • mitochondrial chaperonins
  • mitochondrial matrix
  • immune-regulatory

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Review

16 pages, 1075 KiB  
Review
Mycobacterial Heat Shock Proteins in Sarcoidosis and Tuberculosis
by Anna Dubaniewicz
Int. J. Mol. Sci. 2023, 24(6), 5084; https://doi.org/10.3390/ijms24065084 - 7 Mar 2023
Cited by 8 | Viewed by 2244
Abstract
Pathological similarities between sarcoidosis (SA) and tuberculosis (TB) suggest the role of mycobacterial antigens in the etiopathogenesis of SA. The Dubaniewicz group revealed that not whole mycobacteria, but Mtb-HSP70, Mtb-HSP 65, and Mtb-HSP16 were detected in the lymph nodes, sera, and precipitated immune [...] Read more.
Pathological similarities between sarcoidosis (SA) and tuberculosis (TB) suggest the role of mycobacterial antigens in the etiopathogenesis of SA. The Dubaniewicz group revealed that not whole mycobacteria, but Mtb-HSP70, Mtb-HSP 65, and Mtb-HSP16 were detected in the lymph nodes, sera, and precipitated immune complexes in patients with SA and TB. In SA, the Mtb-HSP16 concentration was higher than that of Mtb-HSP70 and that of Mtb-HSP65, whereas in TB, the Mtb-HSP16 level was increased vs. Mtb-HSP70. A high Mtb-HSP16 level, induced by low dose-dependent nitrate/nitrite (NOx), may develop a mycobacterial or propionibacterial genetic dormancy program in SA. In contrast to TB, increased peroxynitrite concentration in supernatants of peripheral blood mononuclear cell cultures treated with Mtb-HSP may explain the low level of NOx detected in SA. In contrast to TB, monocytes in SA were resistant to Mtb-HSP-induced apoptosis, and CD4+T cell apoptosis was increased. Mtb-HSP-induced apoptosis of CD8+T cells was reduced in all tested groups. In Mtb-HSP-stimulated T cells, lower CD8+γδ+IL-4+T cell frequency with increased TNF-α,IL-6,IL-10 and decreased INF-γ,IL-2,IL-4 production were present in SA, as opposed to an increased presence of CD4+γδ+TCR cells with increased TNF-α,IL-6 levels in TB, vs. controls. Mtb-HSP modulating the level of co-stimulatory molecules, regulatory cells, apoptosis, clonal deletion, epitope spread, polyclonal activation and molecular mimicry between human and microbial HSPs may also participate in the induction of autoimmunity, considered in SA. In conclusion, in different genetically predisposed hosts, the same antigens, e.g., Mtb-HSP, may induce the development of TB or SA, including an autoimmune response in sarcoidosis. Full article
(This article belongs to the Special Issue A New Paradigm for Chaperone Proteins in Health and Disease)
Show Figures

Figure 1

19 pages, 1463 KiB  
Review
Mitochondrial Dysfunction as an Underlying Cause of Skeletal Muscle Disorders
by Tsung-Hsien Chen, Kok-Yean Koh, Kurt Ming-Chao Lin and Chu-Kuang Chou
Int. J. Mol. Sci. 2022, 23(21), 12926; https://doi.org/10.3390/ijms232112926 - 26 Oct 2022
Cited by 19 | Viewed by 3918
Abstract
Mitochondria are an important energy source in skeletal muscle. A main function of mitochondria is the generation of ATP for energy through oxidative phosphorylation (OXPHOS). Mitochondrial defects or abnormalities can lead to muscle disease or multisystem disease. Mitochondrial dysfunction can be caused by [...] Read more.
Mitochondria are an important energy source in skeletal muscle. A main function of mitochondria is the generation of ATP for energy through oxidative phosphorylation (OXPHOS). Mitochondrial defects or abnormalities can lead to muscle disease or multisystem disease. Mitochondrial dysfunction can be caused by defective mitochondrial OXPHOS, mtDNA mutations, Ca2+ imbalances, mitochondrial-related proteins, mitochondrial chaperone proteins, and ultrastructural defects. In addition, an imbalance between mitochondrial fusion and fission, lysosomal dysfunction due to insufficient biosynthesis, and/or defects in mitophagy can result in mitochondrial damage. In this review, we explore the association between impaired mitochondrial function and skeletal muscle disorders. Furthermore, we emphasize the need for more research to determine the specific clinical benefits of mitochondrial therapy in the treatment of skeletal muscle disorders. Full article
(This article belongs to the Special Issue A New Paradigm for Chaperone Proteins in Health and Disease)
Show Figures

Figure 1

Back to TopTop